Please assess the completion status of the following clinical trial:

Trial Title: Study of Atorvastatin Versus Placebo to Reduce Cardiopulmonary Complications After Thoracic Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients ≥ 18 yr. scheduled for anatomic lung resection (segmentectomy, lingulectomy, possible or definite lobectomy, bilobectomy, pneumonectomy or extrapleural pneumonectomy) with or without chest wall resection or limited resection~* Patients with regular cardiac rhythm~* Patients able to take oral capsules~* Patients capable of providing written, informed consent~* Patients without known hepatic or kidney disease~Exclusion Criteria:~* Patients already taking any statin, gemfibrozil (Lopid), or ezetimibe (Zetia)~* Hypersensitivity to atorvastatin~* Chronic atrial fibrillation~* Patients already taking class Ic or III antiarrhythmic drugs~* Known pregnancy a urine pregnancy test will be given to women of childbearing age~* Known history of active hepatic disease or known hepatic insufficiency~* Known history of active kidney disease or insufficiency

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Atorvastatin
- 2 (Type: PLACEBO_COMPARATOR): placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).